Genmark Diagnostics (NASDAQ:GNMK)’s share price plunged -3.85% or -0.19 to reach at $4.74 during previous trading session. A total of 828467 shares exchanged hands, whereas the company’s average trading volume stands at 625.61 Million shares. Genmark Diagnostics (NASDAQ:GNMK) has a market capitalization of $262.88 Million and most recently 55.46 Million outstanding shares have been calculated.

According to sentiments of 7 analysts the mean estimates of short term price target for the company’s stock is marked at $11.36. The most optimistic analyst sees the stock reaching $13.5 while the most conventional predicts the target price at $10.

In terms of Buy/Sell recommendations, 8 analysts have a consensus rating of 1.38 on the shares of Genmark Diagnostics (NASDAQ:GNMK). Out of rating recommendations 4 have given the stock a Buy while 3 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Genmark Diagnostics (NASDAQ:GNMK)’s distance from 20 day simple moving average is -0.3016 along with distance from 50 day simple moving average of 7.93 whereas its distance from 200 day simple moving average is 10.59. Genmark Diagnostics (NASDAQ:GNMK)’s price distance from 52-week high is -65.33 and from 52-week low is 30.58. The stock hit its 52-week high price on 05/09/17, and 52-week low price on 11/06/17. The stock’s 52-week price fluctuated within the range of $13.67 – $3.63.

Genmark Diagnostics (NASDAQ:GNMK)’s shares climbed 24.41% in the past week and plunged -46.68% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -64.76% while its year to date performance is at -61.27%.

While taking a glance at financials, we can look at a number of key indicators. Genmark Diagnostics (NASDAQ:GNMK) has a Return on Assets (ROA) of -57.2. The company currently has a Return on Equity (ROE) of -100.3 and a Return on Investment (ROI) of -84.6. Average true range (ATR-14) of the company sets at 0.53, along with its weekly and monthly volatility of 10.87% and 9.28% respectively. Relative strength index (RSI-14) for Genmark Diagnostics (NASDAQ:GNMK) is at 26.92. Beta value of the stock stands at 0.87.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 2.8 along with current ratio for most recent quarter of 3. Total debt to equity ratio of Genmark Diagnostics (NASDAQ:GNMK) for most recent quarter is 0.36 whereas long term debt to equity ratio for most recent quarter is 0.12.

Shares of Orchid Island Capital Inc Cmn (NYSE:ORC) soared 0.1% or 0.01 to reach at $9.8 during previous trading session. Orchid Island Capital Inc Cmn (NYSE:ORC) has a market capitalization of $452.37 Million and most recently 46.16 Million outstanding shares have been calculated. A total of 879266 shares exchanged hands, whereas the company’s average trading volume stands at 854.16 Million shares.

According to 1 analysts Orchid Island Capital Inc Cmn (NYSE:ORC)’s price will reach at $10 during 52 weeks. Stock’s minimum price target estimates has been figured out at $10 while the maximum price target forecast is established at $10.

According to the recommendations from 2 analysts stock has mean rating of 2 on the shares of Orchid Island Capital Inc Cmn (NYSE:ORC). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Orchid Island Capital Inc Cmn (NYSE:ORC) climbed 0.93% in the past week and plunged -5.68% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -5.41% while its year to date performance is at -9.51%.

Orchid Island Capital Inc Cmn (NYSE:ORC)’s 52-week price fluctuated within the range of $12.60 – $9.18. Its price distance from 52-week high is -22.22 and from 52-week low is 6.75. The stock hit its 52-week high price on 02/14/17, and 52-week low price on 08/01/17. Orchid Island Capital Inc Cmn (NYSE:ORC)’s distance from 20 day simple moving average is-0.0235 along with distance from 50 day simple moving average of 10.14 whereas its distance from 200 day simple moving average is 10.03.

Total debt to equity ratio of Orchid Island Capital Inc Cmn (NYSE:ORC) for most recent quarter is 8.95 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 21.85. Its quick ratio for most recent quarter is 0 along with current ratio for most recent quarter of 0.

Average true range (ATR-14) of the company sets at 0.16, along with its weekly and monthly volatility of 1.13% and 1.72% respectively. Relative strength index (RSI-14) for Orchid Island Capital Inc Cmn (NYSE:ORC) is at 40.58. Beta value of the stock stands at 0.52. Orchid Island Capital Inc Cmn (NYSE:ORC) has a Return on Assets (ROA) of -0.3. The company currently has a Return on Equity (ROE) of -3.3 and a Return on Investment (ROI) of 0.1.